CO6220913A2 - Polimorfos de 3-(e)-2-{2-[6-(2-cianofenoxi)pirimidin-4-iloxi]fenil}-3-metoxiacrilato - Google Patents

Polimorfos de 3-(e)-2-{2-[6-(2-cianofenoxi)pirimidin-4-iloxi]fenil}-3-metoxiacrilato

Info

Publication number
CO6220913A2
CO6220913A2 CO09083638A CO09083638A CO6220913A2 CO 6220913 A2 CO6220913 A2 CO 6220913A2 CO 09083638 A CO09083638 A CO 09083638A CO 09083638 A CO09083638 A CO 09083638A CO 6220913 A2 CO6220913 A2 CO 6220913A2
Authority
CO
Colombia
Prior art keywords
polymorph
exhibits
crystalline polymorph
crystalline
cyanophenoxy
Prior art date
Application number
CO09083638A
Other languages
English (en)
Inventor
Sharona Zamir
Inna Faktorovitch
Original Assignee
Makhteshim Chem Works Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Makhteshim Chem Works Ltd filed Critical Makhteshim Chem Works Ltd
Publication of CO6220913A2 publication Critical patent/CO6220913A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/54—1,3-Diazines; Hydrogenated 1,3-diazines

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Environmental Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

1.- La Forma A polimorfa cristalina de (E)-2-{2-[6-(2-cianofenoxi) pirimidin-4-iloxi] fenil}-3-metoxiacrilato. 2.- La polimorfa cristalina de acuerdo con la reivindicación 1, en donde la polimorfa exhibe un patrón de difracción por rayos X (método con polvo micro-cristalino) que tiene picos característicos expresados en grados 2θ (+/-0.20 °θ) en cerca de 6.25, 13.8, 17.65, 19.05, 26.4 y 28.5. 3.- La polimorfa cristalina de acuerdo con la reivindicación 2, en donde la polimorfa además exhibe picos característicos expresados en grados 2 θ (+/-0.20 °θ) en cerca de 11 y 14.4. 4.- La polimorfa cristalina de acuerdo con la reivindicación 1, en donde la polimorfa exhibe un patrón de difracción por rayos X (método con polvo micro-cristalino) sustancialmente como se muestra en la Figura 1. 5.- La polimorfa cristalina de acuerdo con la reivindicación 1, en donde la polimorfa exhibe un espectro infra-rojo (IR) que tiene picos característicos en cerca de 1378, 1328 y 1154 cm-1 6.- La polimorfa cristalina de acuerdo con la reivindicación 1, en donde la polimorfa exhibe un espectro infra-rojo (IR) sustancialmente como se muestra en la Figura 2. 7.- La polimorfa cristalina de acuerdo con la reivindicación 1, en donde la polimorfa exhibe una endoterma predominante única en un intervalo de cerca de 114-117 °C cuando se mide por calorimetría por Escaneo Diferencial (DSC) a una tasa de escaneo de 10°C por minuto. 8.- La polimorfa cristalina de acuerdo con la reivindicación 1, en donde la polimorfa exhibe un termo-grama por Calorimetría por Escaneo Diferencial (DSC) sustancialmente como se muestra en la Figura 3.
CO09083638A 2007-02-01 2009-08-11 Polimorfos de 3-(e)-2-{2-[6-(2-cianofenoxi)pirimidin-4-iloxi]fenil}-3-metoxiacrilato CO6220913A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL181125A IL181125A0 (en) 2007-02-01 2007-02-01 Polymorphs of 3-(e)-2-{2-[6-(2-

Publications (1)

Publication Number Publication Date
CO6220913A2 true CO6220913A2 (es) 2010-11-19

Family

ID=39674584

Family Applications (1)

Application Number Title Priority Date Filing Date
CO09083638A CO6220913A2 (es) 2007-02-01 2009-08-11 Polimorfos de 3-(e)-2-{2-[6-(2-cianofenoxi)pirimidin-4-iloxi]fenil}-3-metoxiacrilato

Country Status (25)

Country Link
US (4) US8546411B2 (es)
EP (1) EP2129221B1 (es)
JP (1) JP2010517995A (es)
KR (1) KR20090106621A (es)
CN (2) CN101621926A (es)
AU (1) AU2008211532C1 (es)
BR (1) BRPI0806410A8 (es)
CA (2) CA3147003A1 (es)
CO (1) CO6220913A2 (es)
CY (1) CY1120106T1 (es)
DK (1) DK2129221T3 (es)
EC (1) ECSP099555A (es)
ES (1) ES2664416T3 (es)
HR (1) HRP20180530T1 (es)
HU (1) HUE036753T2 (es)
IL (2) IL181125A0 (es)
LT (1) LT2129221T (es)
MX (2) MX2009008138A (es)
NO (1) NO2129221T3 (es)
NZ (3) NZ578632A (es)
PL (1) PL2129221T3 (es)
PT (1) PT2129221T (es)
SI (1) SI2129221T1 (es)
WO (1) WO2008093325A2 (es)
ZA (1) ZA200905119B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL180134A0 (en) 2006-12-17 2007-07-04 David Ovadia Process for the preparation of substituted cyanophenoxy-pyrimidinyloxy -phenyl acrylate derivatives
IL181125A0 (en) * 2007-02-01 2007-07-04 Maktheshim Chemical Works Ltd Polymorphs of 3-(e)-2-{2-[6-(2-
TWI491356B (zh) * 2010-02-23 2015-07-11 Nippon Kayaku Kk Synthesis of 2-ethyl-3,7-dimethyl-6- (4- (trifluoromethoxy) phenoxy) quinolin-4-ylmethyl carbonate and a method for producing the same Crystallization of the pesticide composition
US11632954B2 (en) * 2017-07-17 2023-04-25 Adama Makhteshim Ltd. Polymorphs of 5-fluoro-4-imino-3-methyl-1 -tosyl-3,4-dihydropyrimidin-2-one
CN109384728A (zh) * 2017-08-07 2019-02-26 华东理工大学 嘧菌酯通道型溶剂化物及其制备方法
CN108947915B (zh) * 2018-06-06 2021-07-06 天津大学 嘧菌酯丙酮溶剂化物及制备方法
CN108675963B (zh) * 2018-06-06 2021-07-13 天津大学 嘧菌酯1，4二氧六环溶剂化物及制备方法
CN108947914B (zh) * 2018-06-06 2021-07-23 天津大学 嘧菌酯乙酸溶剂化物及制备方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3789117T2 (de) 1986-04-17 1994-05-26 Zeneca Ltd Fungizide.
US5160530A (en) * 1989-01-24 1992-11-03 Griffin Corporation Microencapsulated polymorphic agriculturally active material
US5145856A (en) * 1989-02-10 1992-09-08 Imperial Chemical Industries Plc Fungicides
US5264440A (en) * 1989-02-10 1993-11-23 Imperial Chemical Industries Plc Fungicides
GB8903019D0 (en) * 1989-02-10 1989-03-30 Ici Plc Fungicides
MY107955A (en) * 1990-07-27 1996-07-15 Ici Plc Fungicides.
GB9122430D0 (en) * 1990-11-16 1991-12-04 Ici Plc Chemical process
US5760250A (en) * 1991-11-05 1998-06-02 Zeneca Limited Process for the preparation of 3-(α-methoxy)methylenebenzofuranones and intermediates therefor
IN179039B (es) 1994-02-08 1997-08-09 Rallis India Ltd
JP3973685B2 (ja) 1995-06-28 2007-09-12 シンジェンタ リミテッド 化学的方法
DE19605901A1 (de) 1996-02-17 1997-08-21 Basf Ag Verfahren zur Herstellung von 2-(2-Methylphenyl)-3-methoxyacrylsäure -methylester
GB9617351D0 (en) 1996-08-19 1996-10-02 Zeneca Ltd Chemical process
GB9622345D0 (en) * 1996-10-28 1997-01-08 Zeneca Ltd Chemical process
JP2000263183A (ja) 1999-03-17 2000-09-26 Pop Rivet Fastener Kk 締結工具の破断片回収装置
US20020042514A1 (en) * 2000-06-26 2002-04-11 Doyle Timothy John Synthesis of chlorinated pyrimidines
GB0114408D0 (en) * 2001-06-13 2001-08-08 Syngenta Ltd Chemical process
DE10351087A1 (de) * 2003-10-31 2005-05-25 Bayer Technology Services Gmbh Feste Wirkstoff-Formulierung
GB0508422D0 (en) * 2005-04-26 2005-06-01 Syngenta Ltd Chemical process
GB0619941D0 (en) * 2006-10-09 2006-11-15 Syngenta Ltd Chemical process
GB0619942D0 (en) 2006-10-09 2006-11-15 Syngenta Ltd Chemical process
IL180134A0 (en) 2006-12-17 2007-07-04 David Ovadia Process for the preparation of substituted cyanophenoxy-pyrimidinyloxy -phenyl acrylate derivatives
IL181125A0 (en) * 2007-02-01 2007-07-04 Maktheshim Chemical Works Ltd Polymorphs of 3-(e)-2-{2-[6-(2-
CN100564362C (zh) * 2007-10-24 2009-12-02 北京颖泰嘉和科技股份有限公司 嘧菌酯及其类似物的制备方法
US8777767B2 (en) * 2012-01-05 2014-07-15 Suncast Technologies, Llc Hybrid play set

Also Published As

Publication number Publication date
HRP20180530T1 (hr) 2018-05-04
EP2129221A2 (en) 2009-12-09
CA2677058A1 (en) 2008-08-07
CA3147003A1 (en) 2008-08-07
US8546411B2 (en) 2013-10-01
IL181125A0 (en) 2007-07-04
NZ604923A (en) 2014-06-27
BRPI0806410A8 (pt) 2019-01-15
MX2020005034A (es) 2022-01-13
ES2664416T3 (es) 2018-04-19
DK2129221T3 (en) 2018-04-09
JP2010517995A (ja) 2010-05-27
US8877767B2 (en) 2014-11-04
EP2129221B1 (en) 2018-01-03
WO2008093325A3 (en) 2009-06-11
US20150057152A1 (en) 2015-02-26
CN103012285A (zh) 2013-04-03
ECSP099555A (es) 2009-09-29
NO2129221T3 (es) 2018-06-02
AU2008211532A1 (en) 2008-08-07
KR20090106621A (ko) 2009-10-09
PL2129221T3 (pl) 2018-07-31
US20140018378A1 (en) 2014-01-16
US8524723B2 (en) 2013-09-03
CN101621926A (zh) 2010-01-06
PT2129221T (pt) 2018-04-05
NZ578632A (en) 2011-11-25
LT2129221T (lt) 2018-04-10
IL200062A0 (en) 2010-04-15
ZA200905119B (en) 2010-05-26
CY1120106T1 (el) 2018-12-12
AU2008211532B2 (en) 2013-09-26
HUE036753T2 (hu) 2018-07-30
SI2129221T1 (en) 2018-05-31
WO2008093325A2 (en) 2008-08-07
AU2008211532C1 (en) 2014-04-10
NZ596178A (en) 2013-06-28
MX2009008138A (es) 2009-08-12
BRPI0806410A2 (pt) 2011-09-06
US20130158054A1 (en) 2013-06-20
US20100173920A1 (en) 2010-07-08

Similar Documents

Publication Publication Date Title
CO6220913A2 (es) Polimorfos de 3-(e)-2-{2-[6-(2-cianofenoxi)pirimidin-4-iloxi]fenil}-3-metoxiacrilato
NZ624315A (en) Crystalline forms of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{ 6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl} -1-methyl-urea and salts thereof.
ES2613716T3 (es) Formas cristalinas de un derivado de purina
NZ596117A (en) Novel anti-inflammatory agents
AR063347A1 (es) Formas cristalinas de docetaxel y proceso para su preparacion
MX349556B (es) Derivados de aminopirimidina como moduladores de proteina cinasa 2 rica en unidades repetitivas de leucina (lrrk2).
MX2014006210A (es) Derivados de 2-(fenil o pirid-3-il)aminopirimidina como moduladores de proteina cinasa 2 de repeticion rica en leucina (lrrk2) para el tratamiento de la enfermedad de parkinson.
GB0510584D0 (en) Organic compounds
AR064165A1 (es) Un procedimiento para la preparacion de capecitabina e intermediarios utilizables en dicho procedimiento
AR067055A1 (es) Procedimiento para la preparacion de rifaximina amorfa y la rifaximina amorfa obtenida de esta forma
IL191555A0 (en) Pyrimidine derivatives for the treatment of abnormal cell growth
ZA200901270B (en) Synthesis of 2-(pyridin-2-ylamino)-pyrido[2,3-D]-pyridimin-7-ones
RS56803B1 (sr) Postupak za proizvodnju 2-[4-(3-ili2-fluorobenziloksi)benzilamino] propanamida sa visokim stepenom čistoće
WO2009118759A3 (en) Heterocyclic compounds as adenosine receptor antagonist
WO2008059368A3 (en) Fused 2-amino pyrimidine compounds and their use for the treatment of cancer
MX340490B (es) Derivados de pirazolo [1, 5a] pirimidina y de tieno [3, 2b] pirimidina como moduladores de la cinasa asociada al receptor de la interleucina 4 (irak4).
EA200970669A1 (ru) Производные 2-амино-5,7-дигидро-6н-пирроло[3,4-d]пиримидина в качестве ингибиторов hsp-90, предназначенные для лечения рака
WO2010089770A3 (en) Processes for preparing pitavas tatin, intermediates and pharmaceutically acceptable salts thereof
UA102289C2 (ru) Гербициды, полученные из циклопентадиона
NZ599138A (en) Purine derivatives useful as hsp90 inhibitors
UA101590C2 (en) Bazedoxifene salt
MX2013005833A (es) Nuevos compuestos de piridina fusionada como inhibidores de caseina quinasa.
NZ594403A (en) Amorphous salt of a macrocyclic inhibitor of hcv
EP2320720A4 (en) CHALUT PANELS FOR REMOTE AND UNDERWATER ADJUSTMENT OF THE ACTIVE SURFACE OF THESE CHALUT PANELS
SG10201902903RA (en) Synthesis and novel salt forms of (r)-5-((e)-2-(pyrrolidin-3-ylvinyl)pyrimidine

Legal Events

Date Code Title Description
FC Application refused